00eMAR systems for UK care homes in 2026
This buyer’s guide is the independent reference for UK care home operators evaluating standalone eMAR systems. It compares the seven dominant dedicated platforms in the UK market on four dimensions: pharmacy integration, barcode verification, care planning fit and CQC compliance. Each profile is built from the supplier’s own current public materials, cross-checked against third-party sources where available.
Author: Liam Palmer, CareTechGuide.co.uk | Last reviewed: 6 May 2026 | Next review: 6 November 2026
Independent research. No platform listed in this guide has paid for inclusion, and CareTechGuide does not accept referral fees, commissions or commercial sponsorship from any of the platforms profiled. The only commercial relationship between Liam Palmer and the platforms in this guide is as an independent commentator on the sector.
What’s in this guide
- Section 1: How to procure an eMAR independently or with expert support
- Section 2: Key considerations, digital MAR vs full eMAR, the three core benefits
- Section 3: At-a-glance comparison table of all 7 platforms
- Section 4: Platform profiles, all 7 standalone eMAR systems
- Section 5: CQC regulations and controlled-drugs compliance context
Who this guide is for
This guide is written for UK care home owners, registered managers, group commercial leads, quality and compliance leads, and anyone responsible for medicines management in residential or nursing care. If you are reviewing your eMAR, comparing platforms, or considering a switch from paper MAR, this is the independent reference.
Disclaimer and corrections
This guide is based on publicly available information from each platform, the trade press and the regulators (CQC, NICE NG46), all checked at the dates noted in the document. Sector data moves; if readers have suggestions for edits, please email [email protected] citing the source and we will update the next review.
Platforms profiled
7The dominant standalone, dedicated UK eMAR systems for residential and nursing care.
Avg medicines / resident / day
7NHS data cited by Omnicell and MED e-care; many residents on 10 or more.
Med errors England / year
237m41.7% occur in care homes (NHS / Omnicell-cited figure).
Reading time
20mOr 4 minutes if you skip straight to the comparison table.
The first decision in choosing an eMAR is not which supplier. It is which care planning system you already use, or plan to.
Which eMAR fits your care operation?
Three quick questions and we will recommend the platforms most likely to suit your setting, care planning system and operation size. No email required.
1. Which care planning system do you use (or plan to use)?
2. What is the setting type?
3. What is the size of your operation?
01How to procure a care home eMAR
Choosing an eMAR system is a major decision for a care home operator. There are two approaches, both valid, but not equal in risk or effort.
What a good procurement process must cover
Beyond features, focus on:
- Interoperability: Real-time integration with care planning (Nourish, PCS mCare, Log my Care, OneAdvanced are the most commonly integrated UK platforms), pharmacy and other systems
- True cost: Implementation, training, scaling and support, not just licence fees
- Digital fit: Alignment with your wider systems and CQC evidence strategy
- Data strategy: Ownership, portability, retention and export
- Implementation quality: Timelines, responsibilities, go-live support
- Service levels: Support availability, SLAs and escalation
Option 1: Procure it yourself
Many providers do this successfully, but there are consistent blind spots: incomplete information (public materials rarely reflect real-world performance, pricing or service quality), biased references (suppliers only share satisfied customers), limited reviews on public platforms, polished demos showing best-case scenarios rather than real-world pressure, and unknown unknowns around data ownership, integrations, SLAs and exit terms. You can still make a good decision; risks increase without deeper insight.
Option 2: Independent expert support
An independent advisor helps close the gaps: unbiased supplier shortlisting based on your needs, access to real-world performance insight (not curated references), support across procurement, contracts and risk areas, contract review before signing, and implementation oversight to ensure delivery matches promises.
Need help choosing an eMAR?
Independent, unbiased support to help care providers shortlist eMAR suppliers, review contracts before signing, and pressure-test supplier claims against real-world residential care requirements.
02Key considerations when choosing an eMAR
2.1 The critical distinction: Basic digital MAR vs full eMAR
Basic digital MAR chart: A digital version of the paper chart. Staff enter medication data manually. Reduces paper but does not eliminate transcription errors and provides no pharmacy integration. Carries most of the same risks as paper MAR.
Full eMAR with pharmacy integration: Medication data flows automatically from the dispensing pharmacy into the system. Prescriptions update in real time. Manual transcription is eliminated. This is the standard CQC inspectors increasingly expect to see, and the standard most multi-site providers are now targeting.
Full eMAR with pharmacy integration is what serious operators are targeting. Basic digital MAR carries most of the same risks as paper.
2.2 Three core benefits of eMAR for care homes
- Reduced medication errors: real-time alerts, barcode verification and pharmacy integration address the primary causes of administration mistakes (transcription error, missed doses, wrong-resident administration)
- Improved efficiency: faster medication rounds and reduced administrative burden. MED e-care’s own materials cite a 30% reduction in med-pass time after eMAR implementation
- Enhanced compliance: full audit trail, missed dose alerts, PRN tracking and CQC-ready reporting from a single system, addressing the key documentation requirements under Regulation 12 (safe care and treatment) and Regulation 17 (good governance)
2.3 Dedicated standalone eMAR for residential care
The suppliers in this guide provide dedicated, specialist eMAR solutions designed for care homes (nursing and residential). These are standalone or hardware-plus-software systems where medication management is the primary product purpose. They integrate with care planning software but are not an all-in-one platform.
03At-a-glance comparison: 7 standalone eMAR platforms for UK care homes
Pharmacy Integration in this table means an automated feed from the dispensing pharmacy into the eMAR, removing manual transcription. Barcode Scan means verification at point of administration: the right resident, right medication, right dose at the right time.
| Supplier | Type | Pharmacy Integration | Care Planning | Barcode | Best For | Tier |
|---|---|---|---|---|---|---|
| ATLAS eMAR (PCS) | Standalone | ATLAS Pharmacy network | PCS mCare (native) | Yes | Care homes on PCS mCare; high-volume nursing | T1 |
| Omnicell | Hardware + Software | Deep; MDS via VBM 200F | Nourish, PCS mCare | Yes | Large nursing homes; bundled hardware | T1 |
| Electronic MAR (Graphix Asset) | SaaS | Pharmacy link | Multiple | Yes | Supported living, LD care, smaller residential | T2 |
| Camascope (formerly VCare) | Standalone | Strong; NHS DM+D | Nourish, PCS mCare, others | Yes | Multi-site groups; 24/7 support | T1 |
| MED e-care | Standalone | Strong; NHS DM+D; open integration | Most major platforms | Yes | Multi-site groups; PainChek partnership | T1 |
| HxCare (Positive Solutions) | Standalone, cloud | Deep; native to Analyst PMR | In development | Not publicly disclosed | Smaller homes on Analyst PMR pharmacies | T2 |
| CareMeds | Standalone, pharmacy-tied | Native (CareMeds ecosystem) | Limited | Yes (2D + photo) | Care homes using CareMeds-dispensing pharmacies | T2 |
04Platform profiles: the 7 standalone eMAR systems for UK care homes
These seven platforms are the dominant standalone, dedicated eMAR systems for UK care home operators. Tier 1 (ATLAS, Omnicell, Camascope, MED e-care) are the established, widely deployed systems with proven track records. Tier 2 (Electronic MAR, HxCare, CareMeds) are credible options for specific contexts.
4.1 ATLAS eMAR (Person Centred Software)
ATLAS eMAR is part of Person Centred Software’s Connected Care Platform, and is now also branded by the supplier as the “Person Centred Software eMAR system (formerly ATLAS eMAR)” on the main PCS product page. Its defining feature is barcode scanning at point of administration: every medication arrives with a unique barcode linked to the resident’s profile, and the system issues a real-time alert if there is any mismatch between medication, dose and resident. For care homes already using PCS mCare (the most widely deployed digital care planning platform in UK social care), ATLAS is the natural and most cost-effective first choice.
Strengths
- Barcode verification at point of care, a strong error-prevention model verified at point of administration
- Native integration with PCS mCare care planning, no data duplication
- Part of the Connected Care Platform including family engagement and wellbeing tools
- Strong CQC audit trail, inspection-ready reporting built in from day one
- Backed by Person Centred Software, which reports 6,000+ care provider customers across the Connected Care Platform
- NHS-accredited (per PCS materials and trade press)
4.2 Omnicell
Omnicell describes itself as the UK’s leading care home medication administration solution, a positioning the supplier publishes on omnicell.co.uk; Person Centred Software publishes a competing “only electronic medication management system in the UK proven to reduce medication errors” claim for ATLAS eMAR. Both are supplier-marketing claims. Omnicell’s hardware-plus-software model supplies automated dispensing units on the pharmacy side (the VBM 200F Automated MDS Filling and Checking Machine), tablets and barcode scanners on the care home side, plus installation, training and technical support as a single package, unmatched for high-volume nursing homes. Omnicell’s public materials emphasise the bundled hardware-plus-software model; operators looking for a software-only deployment should confirm specifically at demo whether this is available and how the commercial terms differ.
Strengths
- Established market presence, recognised by CQC inspectors and pharmacy partners
- Deep pharmacy integration including automated MDS (Monitored Dosage System) dispensing via the Omnicell VBM 200F machine on the pharmacy side
- Full turnkey hardware service for nursing homes: installation, training and support in one relationship
- Confirmed integrations with Nourish Care and Person Centred Software’s mCare
- Well Pharmacy partnership announced 2021 covering 350+ UK care homes
4.3 Electronic MAR by Graphix Asset
Electronic MAR by Graphix Asset is a SaaS eMAR developed by a Bristol-based digital design agency, originally co-created with Hft (a national charity supporting people with learning disabilities). The product covers the full medication administration workflow from pharmacy-linked prescriptions through to point-of-care administration recording, and has since expanded into elderly residential care. It offers a straightforward approach for smaller homes wanting a dedicated eMAR without the hardware commitment of Omnicell. Public profile and deployment scale are smaller than the Tier 1 platforms; ask the supplier for a recent reference of similar scale and care type to your own.
Strengths
- Dedicated eMAR, medication management is the core purpose
- SaaS delivery, no hardware required, accessible pricing
- Pharmacy integration for automated prescription updates
- CQC audit trail and reporting built in
- Particularly well suited to supported living and learning-disability care, where the product originated
4.4 Camascope (formerly VCare Systems)
Camascope is the rebranded name of VCare Systems, the same company and product under a new brand. Both names still appear in the market. Camascope has built a strong reputation for real-time alerts, in-app clinical safeguards and a 24/7 human support model. Missed dose alerts, PRN insights and audit reporting are all built in. User feedback consistently highlights ease of adoption and responsive support. The supplier reports working with hundreds of UK care homes (current website language; an older marketing figure of “2,000+ providers” appeared in earlier materials but is not on the current site).
Strengths
- Dedicated eMAR specialist, medication depth is a core product priority
- 24/7 human support published on the supplier’s site as a differentiator
- Confirmed integrations with Nourish Care and Person Centred Software mCare
- Real-time missed dose alerts and PRN tracking built in as standard
- NHS DM+D (Dictionary of Medicines and Devices) medication database integration
- Offline mode, medicines can be recorded even without internet
- ISO 27001 certified, GDPR-compliant per supplier materials
- Pharmacy partnerships include Boots, LloydsPharmacy and Well Pharmacy
- Caring Homes Group rollout across 21 homes completed May 2025
4.5 MED e-care
MED e-care is a well-established standalone eMAR with an open-integration approach: the supplier integrates with most major UK care planning platforms, including PCS’s Digital Care System. They use NHS DM+D codes and are the preferred choice for providers wanting genuine best-of-breed medication management without being locked into a single software ecosystem. The strategic partnership with PainChek, the world’s first FDA-cleared digital pain assessment tool, was announced 6 November 2025 with a joint launch webinar on 20 November 2025. The integration extends MED e-care’s clinical capability into AI-driven pain assessment, particularly relevant for residents living with dementia.
Strengths
- Open-integration approach, confirmed integrations with most major UK care planning platforms
- NHS DM+D code standards, pharmacy-grade data quality
- No single-vendor dependency, full flexibility in the technology stack
- Named care customers include Bupa (Hazelmere House), Exemplar Health Care, Park Homes UK and Colton Care
- PainChek partnership (6 November 2025), integrated AI-driven pain assessment
- 30% reduction in med-pass time cited in supplier materials
- Pharmacy partners include Boots UK, Remedi Solutions and Bilton Pharmacy
4.6 HxCare (Positive Solutions)
HxCare is a newer eMAR product from Positive Solutions (launched at the Care Show in October 2024), backed by 30+ years of pharmacy software experience. As a relatively new market entrant, deployment scale is materially smaller than the Tier 1 platforms. Developed in close collaboration with care homes to prioritise usability for all technical literacy levels. The standout commercial feature is its pharmacy-funded rollout model: community pharmacies enrolling in the HxCare Affiliate Programme (HxCAP) can subsidise or fully fund the system for their care home clients, removing the upfront cost barrier for smaller homes.
Strengths
- Pharmacy-funded model available; the system is free to community pharmacies signing up to HxCAP
- 30+ years of pharmacy software experience (Positive Solutions is the supplier of Analyst PMR)
- Built with care home staff, focus on usability for non-technical teams
- Deep integration with Analyst PMR (Positive Solutions’ own pharmacy product)
- No hardware dependency, software-only, cloud-based, tablet-based
- Roadmap-driven product with published development cycle
4.7 CareMeds
CareMeds eMAR uses photographic identification of resident and medication, supported by 2D barcodes, linking the care home directly to the pharmacy and eMAR systems. Tightly integrated with the patented MultiMeds blister pack dispensing system. CareMeds Limited was founded in 2012 (Totton, UK) and was acquired by Pharmagest Interactive (now Equasens) in 2017; the supplier-published markets at the time of acquisition were UK, Germany, Portugal, Spain and Malta. CareMeds eMAR is only available to CareMeds pharmacy customers: it is the technology layer of their pharmacy service, not an independent purchase.
Strengths
- Photographic identification of resident and medication, plus 2D barcode verification
- Tightly integrated with the patented MultiMeds blister pack dispensing system (pod-based, removable individual seals)
- Available across UK and selected European markets (Germany, Portugal, Spain, Malta per the 2017 Pharmagest acquisition statement)
- Owned by Equasens (formerly Pharmagest Interactive), a publicly listed French healthcare technology group
- 30,000 patients in care settings supported each month per supplier materials
05CQC, controlled drugs and the case for eMAR
5.1 The underlying need for eMAR in residential care
Medication management in UK care homes is closely regulated because mistakes can seriously harm residents. The CQC requires care providers to manage medicines safely under its Fundamental Standards: medicines must be prescribed correctly, dispensed safely, administered at the correct time and dosage, recorded accurately, and stored and disposed of safely. If medication is handled incorrectly or records are poorly maintained, the service may be judged to have breached these standards, which can lead to enforcement action by the CQC and potentially involve other regulators and safeguarding authorities.
5.2 Categories of medicines and why they matter
Medicines used in residential care settings fall into different categories. General prescription medicines are standard medicines prescribed by a GP or specialist. Over-the-counter medicines must still be recorded if administered by staff. High-risk medicines such as insulin or anticoagulants can cause significant harm if used incorrectly. Controlled drugs (including strong pain relief such as opioids) are regulated under strict legal controls due to their potential for misuse or dependence. Controlled drugs require secure storage in cabinets meeting the Misuse of Drugs (Safe Custody) Regulations 1973, separate registers, strict stock monitoring and witnessed disposal (with witnessed administration as good practice per CQC guidance, where staffing allows).
5.3 Nursing homes vs residential care homes
The demand for eMAR is concentrated in two types of care home. Nursing homes have higher clinical complexity: a registered nurse must be employed, residents typically manage multiple long-term conditions with complex regimes, and there is professional accountability through the Nursing and Midwifery Council (NMC). Omnicell, ATLAS eMAR and MED e-care are typically the strongest fits.
Residential care homes do not require a registered nurse but residents are typically older and managing multiple long-term conditions simultaneously, known as polypharmacy. NHS data cited by Omnicell and MED e-care puts the average at around 7 medicines per resident per day, with many on 10 or more. eMAR is just as important here.
5.4 Controlled drugs, how eMAR helps
Controlled drugs (CDs) in care homes are managed under strict regulations focusing on secure storage in locked, wall-fixed metal cabinets meeting the Misuse of Drugs (Safe Custody) Regulations 1973, meticulous record-keeping in a dedicated CD register, and specialised handling protocols. CQC guidance describes two-staff witnessing as “good practice” rather than a legal requirement for routine administration in care homes; witnessed disposal is required. eMAR systems are specifically designed to support this regulatory burden.
- Secure storage: CDs must be stored in a dedicated, non-portable, locked metal cabinet meeting the Misuse of Drugs (Safe Custody) Regulations 1973
- Recording and audit: A dedicated CD register must be maintained to log all receipts, administrations and disposals. Two-staff auditing is good practice per CQC guidance
- Administration: CQC describes two-staff witnessing of CD administration as good practice rather than a legal requirement; many care homes do operate two-staff witnessing as part of their internal medicines policy
- Receiving and disposal: Disposal requires authorised, legal procedures and is the one stage where two-staff witnessing is explicitly required by regulation
- Policies: Care homes must have written, robust policies including notifying the regional NHS Controlled Drugs Accountable Officer (CDAO) or police when required
5.5 Key CQC regulations
- Regulation 12, Safe Care and Treatment: The core regulation. eMAR supports this through barcode verification, real-time alerts and an unbroken audit trail of every administration
- Regulation 17, Good Governance: Requires accurate, up-to-date records. eMAR replaces paper MAR charts with always-current, time-stamped, tamper-evident records
- Regulation 13, Safeguarding Service Users from Abuse and Improper Treatment: Ensures medication is not used inappropriately. eMAR provides oversight and audit trails
- Mental Capacity Act 2005: Essential for managing covert administration and ensuring consent. eMAR can record consent status, mental capacity assessments and rationale for covert administration decisions
FAQFrequently asked questions
What is the best eMAR system for care homes in 2026?
There is no single best eMAR system for UK care homes; the right choice depends on the size and clinical complexity of the operation, the care planning system already in use, and the dispensing pharmacy. Tier 1 options are ATLAS eMAR (Person Centred Software), Omnicell, Camascope and MED e-care. Tier 2 options are Electronic MAR by Graphix Asset, HxCare (Positive Solutions) and CareMeds.
What is the difference between a digital MAR chart and a full eMAR system?
A basic digital MAR chart is a digital version of the paper chart, with staff entering medication data manually. It reduces paper but does not eliminate transcription errors and has no pharmacy integration. A full eMAR system has automated data flow from the dispensing pharmacy: prescriptions update in real time, manual transcription is eliminated, and barcode verification at point of administration alerts staff to mismatches between medication, dose and resident.
Which eMAR systems integrate with Nourish Care?
Omnicell, Camascope and MED e-care all publish confirmed Nourish Care integrations on their own or Nourish’s websites. ATLAS eMAR integrates natively with PCS mCare rather than Nourish. Operators on Nourish should shortlist Omnicell, Camascope or MED e-care.
Is barcode scanning at point of administration required for CQC compliance?
CQC does not mandate barcode scanning specifically; the regulator requires accurate, evidenced medication administration that meets Regulation 12 (safe care and treatment) and Regulation 17 (good governance). Barcode verification is, however, the strongest available method for preventing wrong-resident or wrong-medication errors. ATLAS eMAR, Omnicell, Camascope, MED e-care and CareMeds all include it.
Does an eMAR system help with controlled drugs management?
Yes. eMAR provides the digital audit trail, witnessed administration recording, stock monitoring and alert systems that paper CD registers struggle to deliver reliably. It does not replace the dedicated CD register or the secure CD cabinet (both regulatory requirements under the Misuse of Drugs (Safe Custody) Regulations 1973), but it significantly strengthens the evidence trail. Two-staff witnessing of CD administration is good practice per CQC guidance, not a legal requirement in care homes.
What does an eMAR system cost in the UK?
Most eMAR suppliers publish contact-for-quote pricing rather than tiered list prices. HxCare’s pharmacy-funded model can deliver the system free to the care home where the dispensing pharmacy is in the HxCAP affiliate programme. CareMeds eMAR is bundled into CareMeds pharmacy dispensing rather than purchased separately. Tier 1 platforms typically price per resident, per site or as an annual licence.
Can a small care home of 20 to 30 beds justify an eMAR?
Yes, and increasingly small homes are adopting eMAR. Medication error and the regulatory risk of poor record-keeping are largely independent of home size, while the time saved on medication rounds and audits scales with the number of medications administered. Smaller homes typically look at SaaS-only options (Electronic MAR by Graphix Asset, Camascope, MED e-care) or the pharmacy-funded HxCare model rather than hardware-bundled Omnicell.
How long does eMAR implementation take in a multi-site care group?
Single-site SaaS deployments can go live in a few weeks. Multi-site rollouts with care planning integration, pharmacy integration and barcode hardware typically take three to six months including pharmacy onboarding, staff training and parallel-running with paper MAR charts. Caring Homes Group’s public Camascope case study (21 homes, completed May 2025) is a useful benchmark for medium-sized group rollouts.
